Oliver Geiseler is a seasoned professional in the pharmaceutical industry, currently serving as the Director and CMC Analytical Lead at Pharvaris since September 2022. Prior to this role, Oliver held several key positions, including Manager of Analytical Development Drug Product at Idorsia Pharmaceuticals Ltd from April 2018 to August 2022, and Analytical Project Manager at Siegfried - Expect More between July 2015 and March 2018. Further experience includes serving as Vice-Head of Quality Control at ChemCon GmbH from December 2012 to June 2015, where Oliver led a team responsible for analytical method development, validation, and stability testing. Oliver completed a doctorate in Organic Chemistry from Karlsruhe Institute of Technology in 2012 and attained an Abitur from Schönborn-Gymnasium Bruchsal in 2002.
This person is not in any teams
This person is not in any offices